Who is in your network?

Global Oxycodone Market to Grow by a Notable CAGR during 2022 – 2030

Research Nester published a report titled “Oxycodone Market: Global Demand Analysis & Opportunity Outlook 2030” which delivers detailed overview of the global oxycodone market in terms of market segmentation by route of administration, application, end-user, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global oxycodone market is anticipated to attain a notable CAGR over the forecast period, i.e., 2022 – 2030. The market is segmented by route of administration into oral, intravenous, and others. Among these segments, the oral segment is anticipated to gain the largest market share over the forecast period owing to the safer action of oxycodone when administered orally. Moreover, the oxycodone tablets contain other drugs, which reduces the abuse potential of the drug, which is estimated to boost the segment growth.
The global oxycodone market is estimated to grow on the back of growing cases of cancer globally. As per the data by the National Cancer Institute, over 18.1 million new cases of cancer were reported globally in 2018. Moreover, the growing medical research activities, along with rising investment in the R&D activities in healthcare sector, are estimated to boost the market growth. Furthermore, oxycodone has lower abuse potential as compared to other opioids, which is projected to fuel the market growth.
On the basis of geographical analysis, the global oxycodone market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the rising cases of cancer in developed nations, along with the presence of major research institutes in the region,. According to the US National Cancer Institute, an estimated of 1,806,590 new cases of cancer were diagnosed in the United States in 2020. Moreover, high healthcare expenditure, and increasing R&D activities, are estimated to boost the market growth.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Rising Prevalence of Cancer Globally to Boost the Market Growth
According to the data by the World Health Organization (WHO), the cancer mortality rate grew from 9.6 million in 2018 to over 10 million in 2020.
Oxycodone is prescribed to cancer patients who experience extreme pain. It is generally given on a regular basis, as it is less addictive, when taken orally. Moreover, the growing demand for opium-based analgesics to relieve the pain for cancer patients is anticipated to boost the market growth.
However, the side effects and addictive nature of opioids are expected to operate as key restraint to the growth of global oxycodone market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global oxycodone market which includes company profiling of Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Bayer AG, Abbott Laboratories, Merck & Co., Inc., Esteve Pharmaceuticals, S.A., Validus Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., and Siemens Healthcare GmbH. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global oxycodone market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Request Report Sample@ https://www.researchnester.com/sample-request-3794
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919

Diabetes Devices Market by Research Nester by USD 48 Billion by 2033

Research Nester assesses the growth of the global diabetes devices market over the forecast period, i.e., 2023-2033, and evaluates its future prospects. Rising prevalence of diabetes among the population of the world, and elevating awareness about diabetes disease to drive market growth. The total population suffering from diabetes in 2019 as per the estimations was over 9% of people which is nearly 460 million people and is projected to reach 570 million with an increase of 10% by 2030 and will reach 690 million with 11% by 2045.
New York – October 10, 2022 - Research Nester’s recent market research analysis on “Diabetes Devices Market: Global Demand Analysis & Opportunity Outlook 2033” delivers a detailed competitors analysis and a detailed overview of the global diabetes devices market in terms of market segmentation by type, distribution channel, end-user, and by region.
Growing Technological Advancements in Diabetes Monitoring Devices to Drive Growth of the Global Diabetes Devices Market
The global diabetes devices market is estimated to grow majorly on account of advancements and developments in technology, science, and manufacturing to enhance the treatment methods of type 1 diabetes. The amount of insulin produced in the diabetes patient is not enough or the body cannot use the insulin generated. To treat such cases, external insulin is injected or given to the patient to regulate the blood glucose levels in diabetic patients. The U.S Food and Drug Administration (FDA), in 2020 approved Minimed770G, a hybrid closed-loop management device that helps users to monitor the sugar levels and estimate the correct dose of insulin.
The market research report on global diabetes devices encompasses an in-depth analysis of the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends. These analyses help organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future. Additionally, the growth opportunities exposed by the market is poised to gain significant momentum in the next few years.
Access our detailed report at:
By type, the global diabetes devices market is segmented into blood glucose monitoring and insulin delivery devices. The insulin delivery devices segment is to garner the highest revenue by the end of 2033 by growing at a significant CAGR over the forecast period. Growing cases of diabetes with complications that are not cured with only medications and rising demand for homecare products during a pandemic. In 2019, as per the estimations, the total blood glucose monitors sold by private labels were 14 million units.
By region, the North America diabetes devices market is to generate the highest revenue by the end of 2033. This growth is anticipated by the rising prevalence of diabetes cases, increasing healthcare expenditure, and the growing presence of dominant players. The U.S health expenditure rose by 9.7% in 2020 and reached USD 4.1 trillion.
The research is global in nature and covers detailed analysis on the diabetes devices market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising of global diabetes devices market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Request strategic sample: https://www.researchnester.com/sample-request-4642
This report also provides the existing competitive scenario of some of the key players of the global diabetes devices market which includes company profiling of Medtronic plc., Abbott Laboratories, Arkray, Inc., Bayer AG, Lifescan, Inc., B. Braun Melsungen AG, Dexcom, Inc., Insulet Corporation, Ypsomed AG, Sanofi, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global diabetes devices market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Request Report Sample@
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919

Stem Cell Treatment Market Size Global Industry Share, and Forecast to 2027

Growing expansions in infrastructure for stem cell banking and processing along with identification of new lines of stem cells will accentuate the market growth across the globe.
The global stem cell treatment market is segmented by stem cell type into embryonic cells, somatic cells and pluripotent cells; by treatment type into allogeneic, auto logic and syngeneic stem cell therapy; by application into regenerative medicine and drug discovery and development; by stem cell technology into cell acquisition, cell production, cryopreservation and expansion and subculture; by end-user into hospitals, ambulatory surgical centers, clinics and others and by regions. Stem cell treatment market is anticipated to mask a CAGR of 12% during the forecast period i.e. 2019-2027.
Growing expansions in infrastructure for stem cell banking and processing along with identification of new lines of stem cells will accentuate the market growth across the globe. Additionally, increasing healthcare expenditures with growing recognition among the population for cellular therapies are expected to boost the market shares robustly over the forecast period. The application of stem cells in treating brain injuries, cerebral palsy, Parkinson’s disease, type 1 diabetes, rheumatoid arthritis and various types of anemia are expected to further the growth of the stem cell treatment market during the forecast period.
Request Sample Report : https://www.researchnester.com/sample-request-1329
North America is expected to display the highest growth owing to the presence of well-developed healthcare infrastructure across the region along with high awareness rate regarding healthcare procedures among the present population. Asia Pacific is estimated to follow North America on the back of rising research investments and growing patient pool across the region as well as the presence of major market players across the countries such as, China, India, Japan and others during the forecast period. Europe is anticipated to showcase a budding growth on the back of growing government initiatives to make the procedure ethically correct.
“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”
Growing Applications due to increasing Chronic Disease Prevalence
With increasing incidences of chronic diseases such as, cancer, sickle cell disease, lymphoproliferative disorders, tumors, and others, the stem cell treatment market is expected to grow on the back of rising awareness among the present population regarding applications of stem cell in these types of disease treatment. Further, the increasing incidences of immune disorders such as severe combined immune deficiency (SCID), neutropenias, phagocyte disorders, inherited disorders of the immune system and other organs are anticipated to increase the market shares over the forecast period.
However, associated cost constraints in the treatment procedure using stem cells are estimated to hinder the growth of the stem cell treatment market during the forecast period.
The report titled “Global Stem Cell Treatment Market: Global Demand Analysis & Opportunity Outlook 2027” delivers detailed overview of the global stem cell treatment market in terms of market segmentation by stem cell type, by treatment type, by application, by stem cell technology, by end-user and by regions.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”
This report also provides the existing competitive scenario of some of the key players of the global stem cell treatment market which includes company profiling of Cytori Therapeutics, Inc., Astellas Pharma., Mesoblast Ltd., Fate Therapeutics Inc., Regeneus Ltd., International Stem Cell Corporation, Pluristem Therapeutics Inc., Thermo Fisher Scientific, Vericel Corporation, Roslin Cells and Other Prominent Players. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global stem cell treatment market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Request Sample Report : https://www.researchnester.com/sample-request-1329
Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.


For more information, please contact:
AJ Daniel

Research Nester
Email: info@researchnester.com
Tel: +1-6465869123

Needle Free Injection Market Growth Analysis and Forecast to 2027

Asia Pacific is anticipated to exhibit a budding growth which is attributed to increasing technological awareness in the present population accompanied with growing healthcare expenditure and rising concerns regarding needle transmitted
The report titled "Global Needle Free Injection Market: Global Demand Analysis & Opportunity Outlook 2027" delivers detailed overview of the global needle free injection market in terms of market segmentation by type, by technology, by site of delivery, by usability, by product, by application, by end-users and by regions.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter's five force model.
The global needle free injection market is segmented by type into powder-based, liquid-based and depot-based needle free injectors; by technology into jet, spring, laser and vibration; by site of delivery into subcutaneous injectors, intramuscular injectors and intradermal injectors; by usability into disposable and reusable; by product into prefilled and fillable needle free injectors; by application into vaccine delivery, insulin delivery, pain management and others; by end-users into hospitals, clinics, home care settings, research laboratories, ambulatory surgical centers etc. and by regions. Needle free injection market is anticipated to mask a CAGR of 12.4% during the forecast period i.e. 2018-2027.
Download Sample of This Strategic Report:https://www.researchnester.com/sample-request-1337
Many multi-national companies are concentrating towards new product advancements in needle free injections to offer many more advantageous properties of these injections. Advancements in healthcare industry in the past few years and growing worldwide healthcare organizational initiatives in order to eliminate needle transmitted diseases is projected to drive the market's growth rapidly. Besides, there is a wide range of functions of these injections in an immense range of applications such as vaccine delivery, insulin delivery, pain management and others that are estimated to boost the market robustly during the forecast period.
On the back of its innate nature to adopt various technologies at their nascent stage of innovation, North America market for needle free injections is anticipated to showcase a flourishing growth over the forecast period. Europe is panned to follow in the footsteps of North America on account of growing geriatric population with decreasing healthcare costs owing to increasing governmental initiatives across the region.
Asia Pacific is anticipated to exhibit a budding growth which is attributed to increasing technological awareness in the present population accompanied with growing healthcare expenditure and rising concerns regarding needle transmitted diseases across the region.
Growing Worldwide Initiatives in order to Eliminate Needle Transmitted Chronic Diseases
The number of chronic diseases has been observed to increase in the past decade on the back of increasing incidences of needle borne injuries and disease transmission. These diseases include hepatitis B, hepatitis C and HIV/AIDS among others for which various government organizations are taking favorable initiatives in order to eliminate them. Some of these organizations are World Health Organization, Center for Disease Control, Gates Foundation etc.
Request Report Sample@ https://www.researchnester.com/sample-request-1337
However, limited usage of needle-free injections for intravenous administration along with priming of the systems before each use is expected to serve as a key restraining factor impacting the worldwide growth of the needle free injection market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global needle free injection market which includes company profiling of Medical International Technology, Inc., Antares Pharma, Inc., PharmaJet, PenJet Corporation, INJEX Pharma AG, Crossject needle-free injection systems, National Medical Products Inc., Valeritas, Inc., European Pharma Group, Endo International PLC and other prominent players. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global needle free injection market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Get more information on this report : https://www.researchnester.com..../reports/needle-free
Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.


For more information, please contact:
AJ Daniel

Research Nester
Email: info@researchnester.com
Tel: +1-6465869123

Polycarbonate Diols Market to Grow with a Notable CAGR During 2021-2029

Research Nester released a report titled “Polycarbonate Diols Market: Global Demand Analysis & Opportunity Outlook 2029” which delivers detailed overview of the global polycarbonate diols market in terms of market segmentation by form, molecular weight, application, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global polycarbonate diols market is segmented by form into solid and liquid, out of which, the solid form segment is anticipated to hold the largest market share by the end of 2029. The growth of the segment can be attributed to the increasing demand for waterborne coatings and paints, coupled with the increasing demand for high-performance synthetic leathers. Waterborne coatings and paints are used in the textile, automotive, and furniture industries as polycarbonate diols are highly resistive to hydrolysis, oxidation, and stain in polyurethane products.
The global polycarbonate diols market is anticipated to grow with a notable CAGR during the forecast period, i.e., 2021-2029. Factors such as the increasing regulatory restrictions on solvent emissions and the awareness for the environment for waste disposal and factory vapor levels are raising the need for the use of water-based polyurethane materials instead of solvent-based materials, which in turn is raising the demand for polycarbonate diols. As polycarbonate diols possess resistive properties for hydrolysis, hence they find wide utilization in polyurethane materials
Regionally, the global polycarbonate diols market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa regions, out of which, the Asia Pacific polycarbonate diols market is anticipated to grab the largest market share. The growth of the market in the region can be attributed to the presence of nations, such as China and India, where the consumption of polycarbonates is significantly high when compared to the world. Moreover, the growing demand for polycarbonates from the end-users who use polycarbonate diols for the manufacturing of different end-use products is also anticipated to drive the growth of the market in the region.

Several Beneficial Attributes of Polycarbonate Diols to Help Expand the Growth of the Market
Polycarbonate diols possess numerous beneficial properties as compared to other polyols. These chemical compounds have excellent hydrolytic stability and low water absorption and can withstand maximum temperature with low-temperature flexibility. Additionally, polycarbonate diols can withstand changing weather and are resistant to UV, chemicals, and oil. Owing to such favorable properties, they are used by manufacturers to manufacture various end-use products, ranging from polyurethane coatings, cast elastomer applications, and adhesives among others. Such a factor is anticipated to drive the growth of the global polycarbonate diols market during the forecast period.
However, concerns for the presence of ecologically harmful compound bisphenol (BPA), which is known to cause health effects on the brain and prostate gland of infants, fetuses, and children, and to disrupt normal hormone levels in human beings, and cause diseases such as cancer, are some of the factors anticipated to limit the growth of the polycarbonate diols market during the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global polycarbonate diols market which includes company profiling of Mitsubishi Chemical Corporation (TYO: 4188), Chemwill Asia co., Ltd, GRR Fine Chem, Saudi Arabian Oil Co. (TADAWUL: 2222), The Perstorp Group, Daicel Corporation (TYO: 4204), Tosoh Corporation (TYO: 4042), Covestro AG (ETR: 1COV), Asahi Kasei Corporation (TYO: 3407), and UBE Industries, Ltd. (TYO: 4208). The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global polycarbonate diols market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Request Report Sample@ https://www.researchnester.com/sample-request-2857
Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919